Medical Innovations, NeoMedigen, Ltd., Biopharmaceutical Companies
CEO Interviews 2013, RezGen5 for the prevention of childhood obesity & aging skin, small molecule formulation for skin care, obesity, longevity, reduce inflammation without steroids, antibiotics, BSX: 6NM
Recent CEO Interviews, Biopharmaceutical Stock, Healthcare Stocks, NeoDerm/ND6, designed to reduce skin inflammation without the need for steroids and antibiotics, compounds that mimic the benefits of a calorie restricted diet and exercise while lowering
Is this your site? Certify your site and update informations
